Business growth: Intelligent failure
About thirty years ago, Eli Lilly and Co., the Indiana-based pharmaceutical company, was conducting clinical trials for a potential blockbuster drug called Alimta for treating lung cancer. The upside was one of huge potential for Lilly. The downside was one of losing millions in research dollars if the development of the drug was unsuccessful. Long story short, the drug failed at first, but Lilly scientists and management, true to their Indiana heritage, failed forward in a way which resulted in yet another blockbuster success for the company.... Read More